Get the Stockscreener App
16.00
1.78%
0.28
Pre-market:
15.82
-0.18
-1.12%
Organon Co stock is traded at $16.00, with a volume of 3.87M.
It is up +1.78% in the last 24 hours and up +6.31% over the past month.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
See More
Previous Close:
$15.72
Open:
$15.65
24h Volume:
3.87M
Relative Volume:
1.28
Market Cap:
$4.12B
Revenue:
$6.41B
Net Income/Loss:
$1.30B
P/E Ratio:
3.1746
EPS:
5.04
Net Cash Flow:
$646.00M
1W Performance:
+6.95%
1M Performance:
+6.31%
6M Performance:
-19.72%
1Y Performance:
-1.23%
1-Day Range:
$15.24
$16.02
1-Week Range:
$14.85
$16.04
52-Week Range:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
16.00 | 4.12B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
787.22 | 707.96B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.64 | 380.36B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
142.27 | 342.53B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
178.50 | 315.43B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
99.85 | 252.58B | 63.17B | 12.15B | 14.84B | 4.77 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Douglas Lane & Associates LLC Sells 260,842 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon continues to partner with VNPA for National Population Action Month - vietnamnews.vn
Organon (OGN) Outpaces Stock Market Gains: What You Should Know - MSN
Range Financial Group LLC Purchases New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Long Term Investment Analysis - Stock Traders Daily
Organon & Co (OGN) Trading 3.21% Higher on Jan 4 - GuruFocus.com
Organon (OGN) Gains As Market Dips: What You Should Know - Yahoo Finance
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks. - The Motley Fool
Organon & Co (OGN) Shares Up 3.14% on Dec 31 - GuruFocus.com
Organon (OGN) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Principal Financial Group Inc. Decreases Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Acquired by Barclays PLC - MarketBeat
Organon Korea sales and customers lead named new head for Organon Malaysia - KBR
Geode Capital Management LLC Acquires 82,220 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Organon CEO to Present at J.P. Morgan Healthcare Conference in January 2025 - StockTitan
Organon's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
Organon's SWOT analysis: stock poised for growth amid challenges - Investing.com
FDA approves Organon’s VTAMA cream, 1% for the treatment for AD - Yahoo Finance
Organon & Co. (NYSE:OGN) Stock Price Down 3.8%Here's Why - MarketBeat
Organon’s steroid-free cream Vtama wins approval in atopic dermatitis - Endpoints News
Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price - Simply Wall St
Te Ahumairangi Investment Management Ltd Reduces Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: healthcare stock navigates growth amid challenges - Investing.com
125,654 Shares in Organon & Co. (NYSE:OGN) Purchased by Neo Ivy Capital Management - MarketBeat
Final Trades: Amazon, American Express and Organon - CNBC
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Fmr LLC Has $34.63 Million Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
Systematic Financial Management LP Has $726,000 Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. announces board member resignation - Investing.com
Organon & Co. announces board member resignation By Investing.com - Investing.com South Africa
Weiss Asset Management LP Acquires New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Trading Report - Stock Traders Daily
Readystate Asset Management LP Has $4.65 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Jacobs Levy Equity Management Inc. Grows Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Edgestream Partners L.P. Buys New Position in Organon & Co. (NYSE:OGN) - MarketBeat
Bridgewater Associates LP Takes Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Charles Schwab Investment Management Inc. Acquires 875,128 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Dynamic Technology Lab Private Ltd Invests $649,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.28%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):